メタ情報
| meta description平均長 | 257.86 |
|---|
| OGPありページ数 | 5 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析（Internal）
| ユニーク内部リンク数 | 261 |
|---|
| ページあたり内部リンク平均 | 83.62 |
|---|
連絡先候補（Contacts）
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析（KeywordMap）
ワードクラウド上位
| 語 | 重み |
|---|
| certification | 1 |
| German | 0.4 |
| has | 0.398542 |
| rapid | 0.362256 |
| SARS | 0.3 |
| CoV | 0.3 |
| test | 0.271692 |
| Rapid | 0.251711 |
| antigen | 0.25 |
| our | 0.243256 |
| Bio | 0.241504 |
| you | 0.229944 |
| Test | 0.228271 |
| Liming | 0.211316 |
| performance | 0.211316 |
| control | 0.211316 |
| detection | 0.211316 |
| products | 0.207519 |
| will | 0.2 |
| PCR | 0.2 |
| win | 0.2 |
| obtained | 0.2 |
| PEI | 0.2 |
| Health | 0.2 |
| virus | 0.2 |
| epidemic | 0.2 |
| quality | 0.197143 |
| service | 0.194568 |
| Coronavirus | 0.188783 |
| Our | 0.17688 |
| Antigen | 0.1625 |
| time | 0.159192 |
| can | 0.159192 |
| tests | 0.15094 |
| countries | 0.15094 |
| Nanjing | 0.15 |
| any | 0.15 |
| Kit | 0.15 |
| Novel | 0.15 |
| production | 0.15 |
| European | 0.15 |
| developed | 0.15 |
| price | 0.15 |
| diagnostic | 0.15 |
| limingbio | 0.15 |
| com | 0.15 |
| verification | 0.15 |
| Paul | 0.15 |
| Ehrlich | 0.15 |
| Federal | 0.15 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| over | world | 3.250163 | 45 |
| Europe | such | 3.09832 | 32 |
| America | Europe | 3.09832 | 32 |
| America | Australia | 3.09832 | 32 |
| Bio | Liming | 2.885503 | 28 |
| CoV | SARS | 2.877375 | 24 |
| Rapid | Test | 2.80002 | 49 |
| Coronavirus | Novel | 2.798509 | 26 |
| long | term | 2.759418 | 24 |
| such | world | 2.721807 | 32 |
| Albicans | Candida | 2.608463 | 20 |
| over | supply | 2.583227 | 32 |
| America | such | 2.437104 | 24 |
| Australia | Europe | 2.437104 | 24 |
| Ehrlich | Paul | 2.403556 | 12 |
| com | limingbio | 2.331322 | 12 |
| supply | will | 2.303374 | 32 |
| Health | Ministry | 2.180723 | 12 |
| over | such | 2.16609 | 24 |
| European | Union | 2.156259 | 11 |
| Real | Time | 2.119331 | 11 |
| Europe | world | 2.114192 | 24 |
| product | will | 2.064167 | 33 |
| self | version | 2.059696 | 9 |
| because | waiting | 2.056024 | 8 |
| developing | specialized | 2.012387 | 8 |
| developing | manufacturing | 2.012387 | 8 |
| diseases | infectious | 2.012387 | 8 |
| Apart | STDs | 2.012387 | 8 |
| Apart | ISO13485 | 2.012387 | 8 |
| ISO13485 | nearly | 2.012387 | 8 |
| CFDA | marked | 2.012387 | 8 |
| CFDA | approved | 2.012387 | 8 |
| shown | similar | 2.012387 | 8 |
| compared | other | 2.012387 | 8 |
| methods | other | 2.012387 | 8 |
| including | methods | 2.012387 | 8 |
| consuming | costly | 2.012387 | 8 |
| Using | costly | 2.012387 | 8 |
| either | patient | 2.012387 | 8 |
| healthcare | patient | 2.012387 | 8 |
| healthcare | professionals | 2.012387 | 8 |
| lot | save | 2.012387 | 8 |
| every | services | 2.012387 | 8 |
| ready | receive | 2.012387 | 8 |
| offered | suggestion | 2.012387 | 8 |
| Marketing | Sales | 2.012387 | 8 |
| Distributor | Marketing | 2.012387 | 8 |
| MDA | Malaysia | 2.012387 | 8 |
| nasopharyngeal | saliva | 2.012387 | 8 |